Patents by Inventor Jonathan Daniel Oliner

Jonathan Daniel Oliner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treatment using specific binding agents of human angiopoietin-2
    Patent number: 7666832
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Grant
    Filed: August 4, 2006
    Date of Patent: February 23, 2010
    Assignee: Amgen Inc.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Angiopoietin-2 Specific Binding Agents
    Publication number: 20090191212
    Abstract: Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
    Type: Application
    Filed: February 19, 2009
    Publication date: July 30, 2009
    Inventors: Jonathan Daniel Oliner, Kevin Graham
  • Angiopoietin-2 specific binding agents
    Patent number: 7521053
    Abstract: Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
    Type: Grant
    Filed: October 10, 2002
    Date of Patent: April 21, 2009
    Assignees: Amgen Inc., Medarex, Inc.
    Inventor: Jonathan Daniel Oliner
  • Specific Binding Agents of Human Angiopoietin-2
    Publication number: 20090054323
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Application
    Filed: December 7, 2007
    Publication date: February 26, 2009
    Applicant: AMGEN INC.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Tumor endothelial marker 7-alpha molecules and uses thereof
    Publication number: 20090053763
    Abstract: The present invention provides Tumor Endothelial Marker 7? (TEM7?) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM7? polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TEM7? polypeptides.
    Type: Application
    Filed: March 10, 2008
    Publication date: February 26, 2009
    Applicant: Amgen, Inc.
    Inventors: Todd Juan, Michael Brian Bass, Jonathan Daniel Oliner
  • Methods of treatment using specific binding agents of human angiopoietin-2
    Patent number: 7205275
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: April 17, 2007
    Assignee: Amgen Inc.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Specific binding agents of human angiopoietin-2
    Patent number: 7138370
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Grant
    Filed: October 10, 2002
    Date of Patent: November 21, 2006
    Assignee: Amgen Inc.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Methods of treatment using specific binding agents of human angiopoietin-2
    Publication number: 20030236193
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Application
    Filed: April 9, 2003
    Publication date: December 25, 2003
    Applicant: Amgen Inc.
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Specific binding agents of human angiopoietin-2
    Publication number: 20030229023
    Abstract: Disclosed are peptides that bind to Ang-2. Also disclosed are peptibodies comprising the peptides, methods of making such peptides and peptibodies, and methods of treatment using such peptides and peptibodies.
    Type: Application
    Filed: October 10, 2002
    Publication date: December 11, 2003
    Inventors: Jonathan Daniel Oliner, Hosung Min
  • Angiopoietin-2 specific binding agents
    Publication number: 20030124129
    Abstract: Disclosed are specific binding agents, such as fully human antibodies, that bind to angiopoietin-2. Also disclosed are heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using the antibodies.
    Type: Application
    Filed: October 10, 2002
    Publication date: July 3, 2003
    Inventor: Jonathan Daniel Oliner
  • Tumore endothelial market 7alpha molecules and uses thereof
    Publication number: 20030092025
    Abstract: The present invention provides Tumor Endothelial Marker 7&agr; (TEM7&agr;) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM7&agr; polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TEM7&agr; polypeptides.
    Type: Application
    Filed: May 28, 2002
    Publication date: May 15, 2003
    Applicant: Amgen, Inc., A Corporation of the State of Delaware
    Inventors: Todd Juan, Michael Brian Bass, Jonathan Daniel Oliner